APA

Scriven J. E., Graham L. M., Schutz C., Scriba T. J., Wilkinson K. A., Wilkinson R. J., Boulware D. R., Urban B. C., Lalloo D. G. & Meintjes G. (20170529). A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis. : The Journal of infectious diseases.

Chicago

Scriven James E, Graham Lisa M, Schutz Charlotte, Scriba Thomas J, Wilkinson Katalin A, Wilkinson Robert J, Boulware David R, Urban Britta C, Lalloo David G and Meintjes Graeme. 20170529. A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis. : The Journal of infectious diseases.

Harvard

Scriven J. E., Graham L. M., Schutz C., Scriba T. J., Wilkinson K. A., Wilkinson R. J., Boulware D. R., Urban B. C., Lalloo D. G. and Meintjes G. (20170529). A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis. : The Journal of infectious diseases.

MLA

Scriven James E, Graham Lisa M, Schutz Charlotte, Scriba Thomas J, Wilkinson Katalin A, Wilkinson Robert J, Boulware David R, Urban Britta C, Lalloo David G and Meintjes Graeme. A Glucuronoxylomannan-Associated Immune Signature, Characterized by Monocyte Deactivation and an Increased Interleukin 10 Level, Is a Predictor of Death in Cryptococcal Meningitis. : The Journal of infectious diseases. 20170529.